Stocks Comparison
Medline vs Solventum: revenue, profit, margins and growth compared
Medline brought in $28.4B of revenue in fiscal 2025, Solventum $8.3B in fiscal 2025. Medline kept 4.1% of its revenue as net profit, Solventum 18.7%. Free cash flow was $1.3B at Medline and -$10M at Solventum.
Side by side, latest fiscal year
| MDLN | SOLV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $28.4B | $8.3B |
| Revenue growth | n/a | +0.9% |
| Net income | $1.2B | $1.6B |
| Net margin | 4.1% | 18.7% |
| Free cash flow | $1.3B | -$10M |
| Free cash flow margin | 4.6% | -0.1% |
| Earnings per share (diluted) | -$0.01 | $8.88 |
| Cash | $1.9B | $878M |
| Debt | $12.6B | $5B |
| Price to earnings | n/a | 10.1 |
| Market value | $45.6B | $15.2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #23 of 523 · Health care | #49 of 523 · Health care |
Over the years
MDLN $28.4BSOLV $8.3B
MDLN $1.2BSOLV $1.6B
MDLN 4.1%SOLV 18.7%
MDLN +9.8%SOLV +0.9%
MDLN $1.3BSOLV -$10M
Questions about Medline and Solventum
Which is bigger by revenue, Medline or Solventum?
Medline is bigger by revenue: $28.4B in fiscal 2025, against $8.3B for Solventum in fiscal 2025.
Which keeps more of its revenue as profit, Medline or Solventum?
Medline had a net margin of 4.1% in fiscal 2025; Solventum had 18.7% in fiscal 2025.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.